Stereotactic body radiation therapy for the treatment of early-stage minimally invasive adenocarcinoma or adenocarcnioma in situ (formerly bronchioloalveolar carcinoma): A patterns of failure analysis

Radiation Oncology

Volumn 8, Issue 1, 2013, Pages

  Badiyan, Shahed N ^a   Bierhals, Andrew J ^a   Olsen, Jeffrey R ^a   Creach, Kimberly M ^a   Garsa, Adam A ^a   DeWees, Todd ^a   Bradley, Jeffrey D ^a   Robinson, Clifford G ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenocarcinoma in situ; BAC; Bronchioloalveolar carcinoma; Minimally invasive adenocarcinoma; SABR; SBRT

Indexed keywords

ACUTE TOXICITY; ARTICLE; BLEEDING; BONE NECROSIS; FISTULA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG NON SMALL CELL CANCER; OVERALL SURVIVAL; PELVIS CANCER; RADIATION DOSE; SPINE METASTASIS; STEREOTACTIC BODY RADIATION THERAPY; TISSUE NECROSIS; ADENOCARCINOMA; ADULT; AGED; BIOPSY; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER SIMULATION; DISEASE FREE SURVIVAL; FEMALE; LUNG ALVEOLUS CELL CARCINOMA; LUNG TUMOR; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; RADIOSURGERY; TREATMENT OUTCOME; VERY ELDERLY;

ADENOCARCINOMA; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA, NON-SMALL-CELL LUNG; COMPUTER SIMULATION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; RADIOSURGERY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84871714656     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-8-4     Document Type: Article

References (34)

1. NCCN Clinical Practice Guidelines in Oncology version 2.2012 2012, National Comprehensive Cancer Network, http://www.nccn.org, NCCN.
2. Fakiris AJ, McGarry RC, Yiannoutsos CT, et al. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys 2009, 75:677-682. 10.1016/j.ijrobp.2008.11.042, 19251380.
3. Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA: j Am Med Assoc 2010, 303:1070-1076.
4. Shibamoto Y, Hashizume C, Baba F, et al. Stereotactic body radiotherapy using a radiobiology-based regimen for stage I nonsmall cell lung cancer: A multicenter study. Cancer 2012, 118:2078-2084. 10.1002/cncr.26470, 22009495.
5. Andratschke N, Zimmermann F, Boehm E, et al. Stereotactic radiotherapy of histologically proven inoperable stage I non-small cell lung cancer: patterns of failure. Radiother oncol: j European Soc Therap Radiol Oncol 2011, 101:245-249.
6. Taremi M, Hope A, Dahele M, et al. Stereotactic body radiotherapy for medically inoperable lung cancer: prospective, single-center study of 108 consecutive patients. Int J Radiat Oncol Biol Phys 2012, 82:967-973. 10.1016/j.ijrobp.2010.12.039, 21377293.
7. Bradley JD, El Naqa I, Drzymala RE, et al. Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the pattern of failure is distant. Int J Radiat Oncol Biol Phys 2010, 77:1146-1150. 10.1016/j.ijrobp.2009.06.017, 19800181.
8. Ricardi U, Filippi AR, Guarneri A, et al. Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial. Lung Cancer 2010, 68:72-77. 10.1016/j.lungcan.2009.05.007, 19556022.
9. Baumann P, Nyman J, Hoyer M, et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J clin oncol: off j Am Soc Clin Oncol 2009, 27:3290-3296.
10. Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/american thoracic society/european respiratory society: international multidisciplinary classification of lung adenocarcinoma: executive summary. Proc Am Thorac Soc 2011, 8:381-385. 10.1513/pats.201107-042ST, 21926387.
11. Noguchi M, Morikawa A, Kawasaki M, et al. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer 1995, 75:2844-2852. 10.1002/1097-0142(19950615)75:12<2844::AID-CNCR2820751209>3.0.CO;2-#, 7773933.
12. Barsky SH, Cameron R, Osann KE, et al. Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathologic features. Cancer 1994, 73:1163-1170. 10.1002/1097-0142(19940215)73:4<1163::AID-CNCR2820730407>3.0.CO;2-J, 8313318.
13. Read WL, Page NC, Tierney RM, et al. The epidemiology of bronchioloalveolar carcinoma over the past two decades: analysis of the SEER database. Lung Cancer 2004, 45:137-142. 10.1016/j.lungcan.2004.01.019, 15246183.
14. Gandara DR, Aberle D, Lau D, et al. Radiographic imaging of bronchioloalveolar carcinoma: screening, patterns of presentation and response assessment. J thoracic oncol: off publ Int Assoc Study Lung Cancer 2006, 1:S20-S26.
15. Sabloff BS, Truong MT, Wistuba II, et al. Bronchioalveolar cell carcinoma: radiologic appearance and dilemmas in the assessment of response. Clin lung cancer 2004, 6:108-112. 10.3816/CLC.2004.n.024, 15476596.
16. Kuriyama K, Seto M, Kasugai T, et al. Ground-glass opacity on thin-section CT: value in differentiating subtypes of adenocarcinoma of the lung. AJR Am j roentgenol 1999, 173:465-469.
17. Raz DJ, Kim JY, Jablons DM. Diagnosis and treatment of bronchioloalveolar carcinoma. Current opinion pulmonary med 2007, 13:290-296.
18. Yap CS, Schiepers C, Fishbein MC, et al. FDG-PET imaging in lung cancer: how sensitive is it for bronchioloalveolar carcinoma?. Eur J Nucl Med Mol Imaging 2002, 29:1166-1173. 10.1007/s00259-002-0853-y, 12192561.
19. Aquino SL, Halpern EF, Kuester LB, et al. FDG-PET and CT features of non-small cell lung cancer based on tumor type. Int j mol med 2007, 19:495-499.
20. Sun JS, Park KJ, Sheen SS, et al. Clinical usefulness of the fluorodeoxyglucose (FDG)-PET maximal standardized uptake value (SUV) in combination with CT features for the differentiation of adenocarcinoma with a bronchioloalveolar carcinoma from other subtypes of non-small cell lung cancers. Lung Cancer 2009, 66:205-210. 10.1016/j.lungcan.2009.01.009, 19203812.
21. Raz DJ, He B, Rosell R, et al. Bronchioloalveolar carcinoma: a review. Clin lung cancer 2006, 7:313-322. 10.3816/CLC.2006.n.012, 16640802.
22. Kim BT, Kim Y, Lee KS, et al. Localized form of bronchioloalveolar carcinoma: FDG PET findings. AJR Am j roentgenol 1998, 170:935-939.
23. NCT00551369 Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed By Surgery 2012, Radiation Therapy Oncology Group, http://www.rtog.org, NCT00551369.
24. NCT00960999 Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer 2012, Radiation Therapy Oncology Group, http://www.rtog.org, NCT00960999.
25. Patsios D, Roberts HC, Paul NS, et al. Pictorial review of the many faces of bronchioloalveolar cell carcinoma. Br J Radiol 2007, 80:1015-1023. 10.1259/bjr/52225107, 17940131.
26. Lee HJ, Lee CH, Jeong YJ, et al. IASLC/ATS/ERS international multidisciplinary classification of lung adenocarcinoma: novel concepts and radiologic implications. J thoracic imaging 2012, 27:340-353.
27. Phase I/II Study of Stereotactic Body Radiotherapy in Medically Inoperable Patients With Centrally Located Stage I Non-Small Cell Lung Cancer Available at http://www.cancer.gov/search/ViewClinicalTrials.aspx?cdrid = 613524&version = HealthProfessional&protocolsearchid = 6830592. Accessed May 24, 2012, Phase I/II Study of Stereotactic Body Radiotherapy in Medically Inoperable Patients With Centrally Located Stage I Non-Small Cell Lung Cancer.
28. Whitson BA, Groth SS, Andrade RS, et al. Invasive adenocarcinoma with bronchoalveolar features: a population-based evaluation of the extent of resection in bronchoalveolar cell carcinoma. J Thorac Cardiovasc Surg 2012, 143:591-600. e591, 10.1016/j.jtcvs.2011.10.088, 22177098.
29. Koike T, Togashi K, Shirato T, et al. Limited resection for noninvasive bronchioloalveolar carcinoma diagnosed by intraoperative pathologic examination. Ann Thorac Surg 2009, 88:1106-1111. 10.1016/j.athoracsur.2009.06.051, 19766789.
30. Sagawa M, Higashi K, Usuda K, et al. Curative wedge resection for non-invasive bronchioloalveolar carcinoma. Tohoku J Exp Med 2009, 217:133-137. 10.1620/tjem.217.133, 19212106.
31. Yamato Y, Tsuchida M, Watanabe T, et al. Early results of a prospective study of limited resection for bronchioloalveolar adenocarcinoma of the lung. Ann Thorac Surg 2001, 71:971-974. 10.1016/S0003-4975(00)02507-8, 11269483.
32. Liu YY, Chen YM, Huang MH, et al. Prognosis and recurrent patterns in bronchioloalveolar carcinoma. Chest 2000, 118:940-947. 10.1378/chest.118.4.940, 11035660.
33. Johnson BE. Second lung cancers in patients after treatment for an initial lung cancer. J Nat Cancer Institute 1998, 90:1335-1345.
34. Ginsberg RJ, Rubinstein LV, . Lung Cancer Study Group Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Ann Thorac Surg 1995, 60:615-622. discussion 622-613, 10.1016/0003-4975(95)00537-U, 7677489, Lung Cancer Study Group.